GlassScriptPhysician profile
Randy G Brown
NPI 1134218662
$3,019.60
in general payments reported to CMS, 2019-2025
25 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $91.50 · 2021: $31.25 · 2022: $923 · 2023: $792 · 2024: $394 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,509.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $942.76 | 2022-2024 | Impella |
| Philips North America LLC | $393.87 | 2019-2024 | (Ck4) Mcot |
| Edwards Lifesciences Corporation | $378.92 | 2021-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $251.03 | 2022-2025 | Aveir, Mitraclip, Gallant |
| Amgen INC. | $250.40 | 2022-2024 | Repatha |
| Bard Peripheral Vascular, INC. | $93.53 | 2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Boston Scientific Corporation | $88.50 | 2023 | Eluvia |
| Medtronic Vascular, INC. | $75.05 | 2020 | |
| Atricure, INC. | $70.52 | 2023 | |
| Pfizer INC. | $70.14 | 2019-2023 | |
| Stryker Corporation | $58.54 | 2023-2025 | Na |
| Merck Sharp & Dohme LLC | $54.02 | 2023-2024 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $43.20 | 2023 | Inpefa |
| Getinge USA Sales, LLC | $37.83 | 2019 | |
| Abbvie INC. | $25.69 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $25.35 | 2023 | Cor Knot |
| Chiesi USA, INC. | $21.76 | 2023 | Cleviprex, Kengreal |
| Lemaitre Vascular, INC. | $19.49 | 2025 | Xenosure Biologic Patch |
| Ethicon US, LLC | $19.47 | 2023 | Echelon Flex, Prolene, Evarrest |
| Daiichi Sankyo INC. | $18.37 | 2024 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.04 | 2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $17.91 | 2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $16.45 | 2020 | |
| Kls-Martin L.P. | $16.33 | 2023 | |
| Hospira, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.